Company Filing History:
Years Active: 2016
Title: Patrick Ming Tat Ling: Innovator in Cancer Treatment
Introduction
Patrick Ming Tat Ling is a notable inventor based in Queensland, Australia. He has made significant contributions to the field of cancer treatment through his innovative research and development of medical devices. His work focuses on utilizing nanotechnology to combat cancer stem cells, which are known for their role in metastasis and treatment resistance.
Latest Patents
Patrick Ming Tat Ling holds a patent for the Nano Cancer Barrier Device (NCBD). This invention aims to immobilize and inhibit the division of metastatic cancer stem cells. The present invention provides methods, compositions, and kits wherein nanomaterials are used for inhibiting cancer stem cell division, colony formation, spheroid formation, and self-renewal. Additionally, it offers methods for treating cancer, coating tumors, and inhibiting metastasis. The invention also includes techniques for inducing cells to enter a state of stasis, isolating tumors, inhibiting bleeding, and marking margins of tumors and organs during surgery with nanomaterials.
Career Highlights
Patrick is affiliated with The University of Hong Kong, where he continues to advance his research in cancer treatment. His work has garnered attention for its potential to improve patient outcomes and provide new avenues for cancer therapy.
Collaborations
Patrick collaborates with Rutledge Ellis-Behnke, a fellow researcher in the field. Their partnership enhances the development and application of innovative solutions in cancer treatment.
Conclusion
Patrick Ming Tat Ling is a pioneering inventor whose work in nanotechnology and cancer treatment holds promise for the future of medical science. His contributions are vital in the ongoing battle against cancer, showcasing the importance of innovation in healthcare.